Amgen R&D Entrusted To Ex-Merck Exec; Today's Launches Given To Morrow

Amgen is turning to former Merck Exec VP-Worldwide Basic Research & Preclinical Development Roger Perlmutter, MD/PhD, to reinvigorate its R&D program.

More from Archive

More from Pink Sheet